New Japan Chemical Co.,Ltd. [4406.T]
TOKYO, May 14 (Pulse News Wire) – New Japan Chemical CO.,LTD. (4406.T) announced today that its board of directors has decided on changes to the company's management structure, effective at the upcoming 154th annual shareholders' meeting scheduled for June 24, 2026.
Key appointments include Masashi Sugimoto as a new outside director, who brings extensive experience in pharmaceuticals and healthcare leadership roles. Sugimoto served as President of Takeda Healthcare Company Limited and later as President of Rohto Pharmaceutical Co., Ltd., among others. He will join the board alongside existing members such as Yoshiro Miura, who will continue as Chairman and Representative Director, and Kaeko Matsuda, who remains as President and Representative Director.
Additionally, Hiromichi Yamahata will take up a position as a new external audit committee member. Yamahata is currently a partner at Shinmaya Law Firm and holds positions as a visiting professor at Doshisha University Graduate School of Law. His expertise includes legal advisory services and corporate governance.
Several executives are set to retire, including Masao Nakagawa, who will transition from his role as Executive Vice President to Advisor, and Hideki Yanase, who will step down as an outside director.
🟡 Confidence: Standard AI-translated content.